ABOUT US
WHAT WE DO
CLINICAL TRIALS AND STUDIES
NEWS
CONTACT
More
AT MEDSIR WE ARE DEDICATED TO OFFER THE MOST RELEVANT NEWS ON THE LATEST ADVANCEMENTS IN ONCOLOGY CLINICAL RESEARCH. FIND OUT THE LATEST NEWS ON ONCOLOGY RESEARCH, REGULATORY APPROVALS, EVENTS, SCIENTIFIC CONFERENCES AND MUCH MORE!
Spotlight – DEBBRAH breast cancer trial
WHAT A 2021 WE HAD!
Spotlight: PHERGain-2 HER2+ early breast cancer trial
MEDSIR at SEOM 2021: Update on the Recruitment Status of the DEBBRAH Study
Dr. José Manuel Pérez Discusses Advances in Treatment Options for HER2+ Breast Cancer
DESTINY-BREAST03 results establish T-DXd as the standard of care for 2L metastatic breast cancer
PARSIFAL: Identifying an endocrine agent for palbociclib in endocrine sensitive ABC
PATHFINDER Study (breast)
Spotlight: PATHFINDER Breast cancer trial
MEDSIR at ESMO 2021: Presentation of DEBBRAH and PATHFINDER study design
COVID-19 Pandemic created a cancer screening deficit in the United States
New trial to evaluate abemaciclib and endocrine therapy vs. chemotherapy in advanced breast cancer
ABIGAIL Study (breast)
Up to 30% of patients with metastatic breast cancer develop brain disease
We explore new ways to treat breast cancer with brain metastases
CAILA Study (breast)
PHERGain-2 Study (Breast)
